Subscribe to Newsletter
Diagnostics Histology, Microbiology and immunology

Case of the Month

A 57-year-old man living in Brazil had a history of chronic intestinal obstipation for over five years. Following serologic and radiologic workup, he underwent resection of the sigmoid and rectum. A 20x225.5 cm segment of markedly dilate large bowel was submitted for histopathological evaluation.

Which of the following infectious agents is the most likely cause of these pathologic changes?

a. Hymenolepis nana
b. Schistosoma mansoni
c. Schistosoma haematobium
d. Strongyloides stercoralis
e. Trypanosoma cruzi

Click here to register your guess.

Do you have an interesting case that you would like us to feature? Email it to [email protected].

A. Malignant PEComa

Histologic sections demonstrate a mesenchymal neoplasm comprised of polygonal perivascular epithelioid cells with granular, eosinophilic-to-clear cytoplasm and large vesicular nuclei with macro-nucleoli. Background showed areas of hemorrhage, focal spindle cell morphology, rare cells with adipocyte morphology, many multinucleated giant cells with pleomorphic nuclei, scattered highly pleomorphic cells, and a focal area of coagulative necrosis. No mitotic figures were identified.  The epithelioid cell component was approximately 90 percent of the tumor volume. Immunostains showed that the epithelioid cells were positive for MART-1 and HMB-45 and focally positive for actin. Desmin was positive in rare cells. The epithelioid cells were negative for pankeratin, AE1/AE3, Cam 5.2, cytokeratin 7, epithelial membrane antigen (EMA), CD10, RCC, CD117, S-100, PAX8, GATA3, and calretinin. Multinucleated cells were highlighted by CD68 and CD163 stains. FISH was negative for TFE3 translocation.

The PEComa family includes angiomyolipoma (AML), lymphangiomyomatosis of the lung, the clear cell “sugar” tumors of lung and other organs, and a rare group of morphologically and immunophenotypically similar tumors occurring throughout the body in soft tissues, viscera, and bones. Most PEComas are benign and predominantly affect women. Folpe et al. described the criteria for classifying PEComas into benign, uncertain malignant potential (size >5 cm or nuclear pleomorphism/multinucleated giant cells only) and malignant (two or more of: size >5 cm, infiltrative, high nuclear grade and cellularity, mitotic rate ≥1/50 HPF, necrosis or vascular invasion).

Renal AMLs account for 1 percent of renal tumors and are commonly associated with tuberous sclerosis complex. Apart from the classic variant, other rare morphologic variants include epithelioid, atypical, oncocytic, clear cell, and cystic. This case demonstrates a morphologic and immunohistochemical neoplasm with melanocytic and myogenic phenotype and >2 criteria for malignant PEComa, supporting a final diagnosis of malignant PEComa.

Submitted by Swati Satturwar, Genitourinary Pathology Fellow, and Rajiv Dhir, Executive Vice-Chair, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Further Reading

  1. G Martignoni et al., “Mesenchymal tumors occurring mainly in adults,” WHO Classification of the Urinary System and Male Genital Organs, 4th Edition, 62. IARC: 2016.
  2. LA Doyle et al., “PEComa,” WHO Classification of Soft Tissue and Bone Tumors, 5th Edition, 312. IARC: 2019.
  3. AL Folpe, DJ Kwiatkowski, Hum Pathol, 41, 1 (2009). PMID: 19604538.
  4. O Mete, TH van der Kwast, Arch Pathol Lab Med, 135, 665 (2011). PMID: 21526965.
  5. Y Yang et al,. J Int Med Res, 48 (2020). PMID: 33070694.
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine